Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01140347
Brief Title: A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib (REACH)

First Submitted : June 2, 2010
First Submitted that Met QC Criteria : June 8, 2010
First Posted : June 9, 2010 (Estimate)

Results First Submitted : March 13, 2015
Results First Submitted that Met QC Criteria : March 13, 2015
Results First Posted : March 26, 2015 (Estimate)

Certification/Extension First Submitted : July 29, 2010
Certification/Extension First Submitted that Met QC Criteria : August 19, 2010
Certification/Extension First Posted : August 23, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : November 24, 2015
Last Update Posted : December 28, 2015 (Estimate)